Investigation of HBV and HCV Co-Infection in 992 HIV/AIDS Patients in Dali City

Abstract

Abstract:

Objective: To investigate and analyze the infection of hepatitis B virus（HBV）and hepatitis C virus（HCV）in 992 HIV/
AIDS patients in Dali City. Methods: The epidemiological data was collected of the 992 HIV/AIDS patients who were confirmed by the
Second People's Hospital of Dali City from January 2005 to July 2018 and were receiving free antiviral treatment at antiviral treatment
sites. Patients were grouped according to whether they were infected with HBV/HCV. The co-infection status of HBV/HCV in HIV/
AIDS patients was statistically analyzed. Results: Among 992 HIV/AIDS patients, the infection rate of HBV was 3.23%（32 cases）,
the infection rate of HCV was 32.26%（320 cases）, and the co-infection rate of HBV and HCV was 2.52%（25 cases）. Among the
patients with HIV/HCV co-infection, the proportion of middle-aged Han males with intravenous drug abuse was the highest, and
compared with the HIV/AIDS patients group, the difference was statistically significant（P<0.05）. Conclusion: Among 992 adults with
HIV/AIDS in Dali City, the infection rate of HBV/HCV was higher than that of the whole country, and among the patients with HIV and
HCV, drug users were the major ones.

Key words: AIDS, HIV, hepatitis B virus, hepatitis C virus, co-infection

CLC Number:

R512.91

HAN Ting-Ting, ZHANG Jian-Bei, SHEN Yuan-Yang. Investigation of HBV and HCV Co-Infection in 992 HIV/AIDS Patients in Dali City[J]. , 2019, 4(8): 93-96.

References

〔1〕World Health Organization. Viral suppression for HIV treat?
ment success and prevention of sexual transmission of
HIV〔EB/OL〕.〔2019-01-07〕.http：// www.who.int/hiv/me?
diacentre/news/viral-supression-hiv-transmission/en/.
〔2〕中国疾病预防控制中心，性病艾滋病预防控制中心，
性病控制中心. 2018 年第2 季度全国艾滋病性病疫
情〔J〕.中国艾滋病性病，2018，24（8）：755.
〔3〕ZHANG F J，ZHU H，WU Y S，et al. HIV，hepatitis B virus，
and hepatitis C virus co-infection in patients in the China

National Free Antiretroviral Treatment Program，2010-12：
a retrospective observational cohort study〔J〕. Lancet Infect
Dis，2014，14（11）：1065-1072.
〔4〕KOURTIS A P，BULTERYS M，HU D J，et al. HIV-HBV
Coinfection：A Global Challenge〔J〕. N Engl J Med，2012，
366（19）：1749-1752.
〔5〕中华医学会感染病学分会艾滋病学组.艾滋病诊疗指南
（2011版）〔J〕.中华传染病杂志，2011，29（10）：629-640.
〔6〕中华医学会肝病学分会，中华医学会感染病学分会. 慢
性乙型肝炎诊断标准（2015年版）〔J〕.中西医结合肝病
杂志，2015，25（6）：384-386.
〔7〕中华医学会肝病学分会，中华医学会感染病学分会.《丙型
肝炎防治指南》2015 年更新版〔J〕. 实用肝脏病杂志，
2016，19（4）：521-538.
〔8〕张国民，缪宁，郑徽，等.中国2005—2016年乙型病毒性
肝炎报告发病的年龄和地区特征〔J〕.中国疫苗和免疫，
2018，24（2）：121-126.
〔9〕秦倩倩，郭巍，王丽艳，等.1997—2011年中国丙型肝炎流行
特征分析〔J〕.中华流行病学杂志，2013，34（6）：548- 551.
〔10〕THIO C L. Hepatitis B and human immunodeficiency virus
coinfection〔J〕. Hepatology，2009，49（S5）：138-145.
〔11〕刘金花，赵艳，孙焕芹，等. HCV对HIV/HCV共感染患
者病情进展的影响〔J〕. 临床肝胆病杂志，2014，30（6）：
501-504.
〔12〕HOFFMANN C J，SEABERG E C，YOUNG S，et al. Hep?
atitis B and long-term HIV outcomes in coinfected HAART
recipients〔J〕. AIDS，2009，23（14）：1881-1889.
〔13〕张超，付钰淋，任强，等. 陕西省HIV/AIDS 合并感染
HBV病例分析〔J〕.预防医学，2018，30（9）：889-892.
〔14〕陈超，游晶，杨微波，等. HIV/AIDS合并乙型肝炎病毒
和（或）丙型肝炎病毒感染的研究进展〔J〕. 中国全科医学，
2012，15（9）：955-958.

[1]	Chen Yonggang,Lu Hongwei,Luo Ji,Liu Xing . Efficacy Analysis of Fluconazole and Voriconazole in Treating Oral Candida Infection Complicated with AIDS [J]. Journal of Dali University, 2020, 5(8): 27-30.
[2]	Li Hongliu, Zhang Jianbo, Luo Hui, Zhou Xuying Han Tingting, Shen Yuanying . Epidemiological Characteristics of Elderly HIV/AIDS Patients Treated with HAART in Dali [J]. Journal of Dali University, 2020, 5(8): 74-78.
[3]	Yang Lifen, Huang Lihua. Analysis of Survival Time and Influencing Factors of HIV/AIDS Patients in Dali Prefecture from 1990 to 2015 [J]. Journal of Dali University, 2020, 5(8): 79-82.
[4]	Wang Ji, Bin Songtao, Li Ming, Tan Li. Ordinary COVID-19 Associated with HIV Infection: A Case Report and Literature Analysis [J]. Journal of Dali University, 2020, 5(10): 20-23.
[5]	Chen Xiaoming, Huang Lihua. Analysis on the Survival Status of HIV/AIDS Patients in Dali City [J]. Journal of Dali University, 2020, 5(10): 80-83.
[6]	ZHANG Min, LIU Ji-Zheng, SHEN Yuan-Yang. Analysis of Sentinel Surveillance Results Among Female Sex Workers in One City of Yunnan Province [J]. , 2019, 4(8): 97-100.
[7]	HAO Xian-Bin, NIE Heng, WANG Xu-Dong, TUN Li-Xian. Study on the Application of PFGE in Mtb Genotyping of HIV/Mtb Co-infection [J]. , 2019, 4(4): 26-30.
[8]	LI Yun, SHI Hui-Xian. CT Diagnostic Method and a Literature Review of Pneumocystis Pneumonia Secondary to AIDS [J]. , 2019, 4(4): 83-86.
[9]	LI Yun, SHI Hui-Xian. CT Diagnosis of Renal Aspergillosis Infections in AIDS Patients [J]. , 2018, 3(4): 76-79.
[10]	Gao Bo, Sun Jingjing, Duan Yuexun, Deng Gang, Yang Qian, Wang Lin, Pan Yun. Analysis on Epstein-Barr Virus Infection in AIDS-related Diffuse Large B-cell Lymphoma [J]. , 2017, 2(4): 59-62.
[11]	Zhang Chao, Zheng Gang, Rao Tao, Dou Jichen, Liu Wei, Cun Xinhua. Clinical Study of Surgical Treatment of HIV Patients Complicated with Orthopedic Diseases [J]. J4, 2016, 1(8): 51-55.
[12]	Guo Yingwu, Bai Jingsong, Liu Jun, Wang Weibo, He Rong, Hou Wei. Clinical Observation of HAART in HIV/AIDS Patients of MSM [J]. J4, 2016, 1(4): 80-82.
[13]	Chen Yuanling, Su Lina. Participatory Evaluation of Education Effect about AIDS Prevention among Medical College Students [J]. J4, 2016, 1(4): 92-94.
[14]	Wang Tao, Zhang Lei, Pan Yunhua, Wu Lixian, Bai Li, Wu Youcong. Investigation on the Carrier Rate of Hepatitis B Virus of College Students in a University in Yunnan [J]. J4, 2016, 1(10): 73-76.
[15]	Li Ze, Liu Jizheng, Shen Yuanying. Investigation on the Infection of HIV, HCV and Association High Risk Factors among Drug Users [J]. J4, 2016, 1(10): 77-80.